Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-088167
Filing Date
2025-06-20
Accepted
2025-06-20 07:00:12
Documents
1
Period of Report
2025-06-18

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3898
  Complete submission text file 0000950170-25-088167.txt   5446
Mailing Address AIMMUNE THERAPEUTICS, INC. 8000 MARINA BOULEVARD, SUITE 300 BRISBANE CA 94005
Business Address
Dallas Jayson Donald Alexander (Reporting) CIK: 0001650322 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39655 | Film No.: 251059048

Mailing Address 75 STATE STREET SUITE 100 BOSTON MA 02109
Business Address 75 STATE STREET SUITE 100 BOSTON MA 02109 45-70-70-52-10
Galecto, Inc. (Issuer) CIK: 0001800315 (see all company filings)

EIN.: 371957007 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)